XImmune Overview
- Year Founded
-
2009
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
XImmune General Information
Description
Developer of a drug research center designed to turn natural immunity into drugs. The company's drug research center utilize endogenous peptides as novel modulators to develop a peptide-based anti-inflammatory treatment for sepsis, enabling patients to consume necessary drugs without any side effects.
Contact Information
Website
www.ximmune.comCorporate Office
- LU Innovation System
- Box 117
- 221 00 Lund
- Sweden
Corporate Office
- LU Innovation System
- Box 117
- 221 00 Lund
- Sweden
XImmune Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Oct-2015 | Completed | Out of Business | |||
| 3. Buyout/LBO (Secondary) | 01-May-2014 | Completed | Startup | |||
| 2. Secondary Transaction - Private | 01-Jan-2009 | $1.36M | Completed | Startup | ||
| 1. Early Stage VC | 01-Jan-2009 | $1.36M | $1.36M | Completed | Startup |
XImmune Patents
XImmune Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-2500184-A | Polypeptide derived from helix a of heparin cofactor ii | Inactive | 12-Mar-2012 | ||
| GB-201204283-D0 | Polypeptides and uses thereof | Inactive | 12-Mar-2012 | ||
| AU-2010299630-A1 | Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity | Inactive | 22-Sep-2009 | ||
| AU-2010299630-A2 | Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity | Inactive | 22-Sep-2009 | ||
| CA-2774288-A1 | Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity | Inactive | 22-Sep-2009 | C07K14/8121 |
XImmune FAQs
-
When was XImmune founded?
XImmune was founded in 2009.
-
Where is XImmune headquartered?
XImmune is headquartered in Lund, Sweden.
-
What industry is XImmune in?
XImmune’s primary industry is Drug Discovery.
-
Is XImmune a private or public company?
XImmune is a Private company.
-
What is XImmune’s current revenue?
The current revenue for XImmune is .
-
How much funding has XImmune raised over time?
XImmune has raised $1.36M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process